Biological Phenotypes of Heart Failure With Preserved Ejection Fraction

被引:180
作者
Lewis, Gavin A. [1 ,2 ]
Schelbert, Erik B. [3 ,4 ,5 ]
Williams, Simon G. [2 ]
Cunnington, Colin [1 ,6 ]
Ahmed, Fozia [1 ,6 ]
McDonagh, Theresa A. [7 ]
Miller, Christopher A. [1 ,2 ,8 ]
机构
[1] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Cardiovasc Sci,Sch Med Sci, Oxford Rd, Manchester M13 9PL, Lancs, England
[2] Univ Hosp South Manchester NHS Fdn Trust, Manchester, Lancs, England
[3] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA
[4] UPMC Cardiovasc Magnet Resonance Ctr, Heart & Vasc Inst, Pittsburgh, PA USA
[5] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA USA
[6] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Heart Ctr, Manchester Acad Hlth Sci Ctr, Oxford Rd, Manchester, Lancs, England
[7] Kings Coll Hosp London, London, England
[8] Univ Manchester, Wellcome Ctr Cell Matrix Res, Div Cell Matrix Biol & Regenerat Med, Sch Biol,Fac Biol Med & Hlth,Manchester Acad Hlth, Oxford Rd, Manchester, Lancs, England
关键词
diastolic dysfunction; ejection fraction; heart failure; heart failure with preserved ejection fraction; myocardial fibrosis; titin; ABNORMAL CALCIUM HOMEOSTASIS; LEFT-VENTRICULAR HYPERTROPHY; NEPRILYSIN INHIBITOR LCZ696; ARTERIAL WAVE REFLECTIONS; AIR-FLOW OBSTRUCTION; DIASTOLIC DYSFUNCTION; MYOCARDIAL FIBROSIS; PULMONARY-HYPERTENSION; EXERCISE CAPACITY; OLDER PATIENTS;
D O I
10.1016/j.jacc.2017.09.006
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Heart failure with preserved ejection fraction (HFpEF) involves multiple pathophysiological mechanisms, which result in the heterogeneous phenotypes that are evident clinically, and which have potentially confounded previous HFpEF trials. A greater understanding of the in vivo human processes involved, and in particular, which are the causes and which are the downstream effects, may allow the syndrome of HFpEF to be distilled into distinct diagnoses based on the underlying biology. From this, specific interventions can follow, targeting individuals identified on the basis of their biological phenotype. This review describes the biological phenotypes of HFpEF and therapeutic interventions aimed at targeting these phenotypes. (C) 2017 by the American College of Cardiology Foundation.
引用
收藏
页码:2186 / 2200
页数:15
相关论文
共 127 条
[1]
Metabolic Modulator Perhexiline Corrects Energy Deficiency and Improves Exercise Capacity in Symptomatic Hypertrophic Cardiomyopathy [J].
Abozguia, Khalid ;
Elliott, Perry ;
McKenna, William ;
Phan, Thanh Trung ;
Nallur-Shivu, Ganesh ;
Ahmed, Ibrar ;
Maher, Abdul R. ;
Kaur, Kulvinder ;
Taylor, Jenny ;
Henning, Anke ;
Ashrafian, Houman ;
Watkins, Hugh ;
Frenneaux, Michael .
CIRCULATION, 2010, 122 (16) :1562-U56
[2]
Abnormal calcium homeostasis in heart failure with preserved ejection fraction is related to both reduced contractile function and incomplete relaxation: an electromechanically detailed biophysical modeling study [J].
Adeniran, Ismail ;
MacIver, David H. ;
Hancox, Jules C. ;
Zhang, Henggui .
FRONTIERS IN PHYSIOLOGY, 2015, 6
[3]
Airflow obstruction, lung function, and risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study [J].
Agarwal, Sunil K. ;
Heiss, Gerardo ;
Barr, R. Graham ;
Chang, Patricia P. ;
Loehr, Laura R. ;
Chambless, Lloyd E. ;
Shahar, Eyal ;
Kitzman, Dalane W. ;
Rosamond, Wayne D. .
EUROPEAN JOURNAL OF HEART FAILURE, 2012, 14 (04) :414-422
[4]
The Effects of Bariatric Surgery on Cardiac Structure and Function: a Systematic Review of Cardiac Imaging Outcomes [J].
Aggarwal, Ravi ;
Harling, Leanne ;
Efthimiou, Evangelos ;
Darzi, Ara ;
Athanasiou, Thanos ;
Ashrafian, Hutan .
OBESITY SURGERY, 2016, 26 (05) :1030-1040
[5]
Novel biomarkers in chronic heart failure [J].
Ahmad, Tariq ;
Fiuzat, Mona ;
Felker, G. Michael ;
O'Connor, Christopher .
NATURE REVIEWS CARDIOLOGY, 2012, 9 (06) :347-359
[6]
Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction [J].
Anand, Inder S. ;
Claggett, Brian ;
Liu, Jiankang ;
Shah, Amil M. ;
Rector, Thomas S. ;
Shah, Sanjiv J. ;
Desai, Akshay S. ;
O'Meara, Eileen ;
Fleg, Jerome L. ;
Pfeffer, Marc A. ;
Pitt, Bertram ;
Solomon, Scott D. .
JACC-HEART FAILURE, 2017, 5 (04) :241-252
[7]
Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction Findings From the I-PRESERVE Trial [J].
Anand, Inder S. ;
Rector, Thomas S. ;
Cleland, John G. ;
Kuskowski, Michael ;
McKelvie, Robert S. ;
Persson, Hans ;
McMurray, John J. ;
Zile, Michael R. ;
Komajda, Michel ;
Massie, Barry M. ;
Carson, Peter E. .
CIRCULATION-HEART FAILURE, 2011, 4 (05) :569-577
[8]
Impact of Noncardiac Comorbidities on Morbidity and Mortality in a Predominantly Male Population With Heart Failure and Preserved Versus Reduced Ejection Fraction [J].
Ather, Sameer ;
Chan, Wenyaw ;
Bozkurt, Biykem ;
Aguilar, David ;
Ramasubbu, Kumudha ;
Zachariah, Amit A. ;
Wehrens, Xander H. T. ;
Deswal, Anita .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (11) :998-1005
[9]
Body Mass Index, Abdominal Fatness, and Heart Failure Incidence and Mortality A Systematic Review and Dose-Response Meta-Analysis of Prospective Studies [J].
Aune, Dagfinn ;
Sen, Abhijit ;
Norat, Teresa ;
Janszky, Imre ;
Romundstad, Pal ;
Tonstad, Serena ;
Vatten, Lars J. .
CIRCULATION, 2016, 133 (07) :639-649
[10]
Percent Emphysema, Airflow Obstruction, and Impaired Left Ventricular Filling [J].
Barr, R. Graham ;
Bluemke, David A. ;
Ahmed, Firas S. ;
Carr, J. Jeffery ;
Enright, Paul L. ;
Hoffman, Eric A. ;
Jiang, Rui ;
Kawut, Steven M. ;
Kronmal, Richard A. ;
Lima, Joao A. C. ;
Shahar, Eyal ;
Smith, Lewis J. ;
Watson, Karol E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (03) :217-227